A unique case has emerged as a two-year-old boy from Haverhill, Suffolk, is the only known individual globally with a severe condition that manifested with involuntary shaking of his left arm soon after birth. Oli-Jay Morris’s health deteriorated rapidly, culminating in a critical seizure shortly after he turned two, leading to his admission to intensive care.
Following extensive medical evaluations, on August 20, it was confirmed that Oli-Jay has EMPF1, a rare gene mutation that medical professionals have not encountered previously, without any existing cure. To address his urgent care needs, his family is now seeking a specialized analysis from an American company, which comes with a price tag of £14,000. This has prompted a fundraising initiative to support Oli-Jay’s immediate treatment and to explore potential long-term solutions for his condition.
Melanie, Oli-Jay’s mother, shared, “We’re cherishing every moment with him as we navigate this uncertain journey. Our lives have been completely upended by his illness.” Oli-Jay’s health challenges began with sudden seizures, leading to his hospitalization and intensive care treatment at Addenbrooke’s Hospital in Cambridge.
Despite waking up from a coma after six days, Oli-Jay’s condition requires constant monitoring, specialized feeding through tubes, and a complex medication regimen due to brain damage sustained during the initial seizure episode. His ability to communicate and move voluntarily has been severely impacted, and he requires frequent hospitalization for various complications affecting his senses and breathing.
Melanie, who has been tirelessly caring for Oli-Jay alongside family support, expressed the emotional toll of the situation, stating, “Every moment is filled with anxiety as we strive to provide the best care for Oli-Jay.” The family received the devastating diagnosis of EMPF1, a rare and fatal condition resulting from a DNM1L gene mutation, with no known cure available.
In a bid to explore potential treatment options, Oli-Jay’s family reached out to the DNM1L Foundation in the United States, which led them to a groundbreaking genetic analysis program offered by Unravel Biosciences. Despite the lengthy timeline for developing a tailored treatment plan, the family is determined to secure the necessary funds to expedite the process, fearing the worsening of Oli-Jay’s condition if immediate action is not taken.
To support Oli-Jay’s medical journey, his aunt Paige initiated a fundraising campaign, which has garnered significant contributions, nearing the target goal of £14,000. Melanie remains hopeful that exceeding this target will pave the way for a potential cure not only for Oli-Jay but for all individuals affected by DNM1L mutations.
Reflecting on her aspirations for her son’s recovery, Melanie emphasized, “As a mother, my ultimate wish is for a miracle to heal Oli-Jay and to find a lasting remedy for all children enduring similar challenges.”